These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36215914)

  • 1. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network.
    Lépine B; Debin M; Dassieu L; Gimenez L; Palmaro A; Ponté C; Swital M; Lapeyre-Mestre M; Blanchon T; Dupouy J
    J Subst Abuse Treat; 2022 Dec; 143():108891. PubMed ID: 36215914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network.
    Lépine B; Debin M; Dassieu L; Gimenez L; Palmaro A; Ponté C; Swital M; Lapeyre-Mestre M; Blanchon T; Dupouy J
    Therapie; 2024 Apr; ():. PubMed ID: 38729825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Care of Opioid use Disorder: The End of "the French Model"?
    Dupouy J; Maumus-Robert S; Mansiaux Y; Pariente A; Lapeyre-Mestre M
    Eur Addict Res; 2020; 26(6):346-354. PubMed ID: 32155620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine.
    Gimenez L; Bonis D; Morel M; Palmaro A; Dassieu L; Dupouy J
    J Subst Use Addict Treat; 2024 Jan; 156():209182. PubMed ID: 37858793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.
    ESUB-MG Study Group
    BMC Fam Pract; 2016 Mar; 17():24. PubMed ID: 26931763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population.
    Hallowell BD; Chambers LC; Samuels EA; Bratberg J; McDonald J; Nitenson A; Onyejekwe C; Beaudoin FL
    Drug Alcohol Depend; 2022 Dec; 241():109680. PubMed ID: 36335834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes.
    Nguyen B; Zhao C; Bailly E; Chi W
    J Gen Intern Med; 2024 Jan; 39(1):95-102. PubMed ID: 37670069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine prescription by general practitioners in a French region.
    Thirion X; Lapierre V; Micallef J; Ronflé E; Masut A; Pradel V; Coudert C; Mabriez JC; Sanmarco JL
    Drug Alcohol Depend; 2002 Jan; 65(2):197-204. PubMed ID: 11772481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
    Longman C; Lintzeris N; Temple-Smith M; Gilchrist G
    Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Analgesics Prescription to End-of-Life Cancer Patients: Characteristics, Attitudes, and Practices of French General Practitioners.
    Janah A; Rey D; Bouhnik AD; Mancini J; Sarradon-Eck A; Verger P; Peretti-Watel P; Bendiane MK
    J Palliat Med; 2018 Dec; 21(12):1741-1748. PubMed ID: 30183469
    [No Abstract]   [Full Text] [Related]  

  • 13. What the X? Understanding changes in buprenorphine prescribing regulation.
    Speight C
    J Am Assoc Nurse Pract; 2024 Mar; 36(3):147-150. PubMed ID: 37646580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
    Krupp J; Hung F; LaChapelle T; Yarrington ME; Link K; Choi Y; Chen H; Marais AD; Sachdeva N; Chakraborty H; McKellar MS
    South Med J; 2023 Apr; 116(4):333-340. PubMed ID: 37011580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full agonist opioid prescribing by primary care clinicians after buprenorphine training.
    Gadomski A; Anderson J; Chung YK; Krupa N; Jenkins P
    Subst Abus; 2022; 43(1):69-75. PubMed ID: 32150525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine Use in the United States, 2010-2019.
    Thompson MG; Kuriyama A; Yoshino T; Murphy MG; Jackson JL
    Am J Med; 2024 Mar; 137(3):280-283. PubMed ID: 37984777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of opiate use disorders in France: results of an observational survey of general practitioners.
    Poloméni P; Bronner C; Fry F; Ravoninjatovo B; Fatseas M
    Addict Sci Clin Pract; 2015 Jun; 10():16. PubMed ID: 26117831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.